barely significantp = 0.06
Barely significant differences were present in total cholesterol (p = 0.06), LDL cholesterol (p = 0.07) and triglycerides levels (p = 0.06), urine potassium (p = 0.07), and in the percentage of SGLT2-inhibitors users (p = 0.07).